The impact of linac output variations on dose distributions in helical tomotherapy 
2006). Using the Hi-Art
TM unit (TomoTherapy, Inc., Madison, WI), radiation is delivered from a 6 MV linear accelerator (linac), with an intensity modulated x-ray fan beam that rotates on a ring-style gantry, while the patient is simultaneously translated into the bore on a treatment couch. The width of the fan beam is controlled by a set of tungsten jaws. The fan beam is divided into beamlets by a binary multileaf collimator (MLC) with 64 leaves, each with a projection at isocentre of 6.25 mm. The intensity of each beamlet is modulated by controlling the amount of time its leaf is open during the 51 angular increments, corresponding to about 7
• each, in which the gantry rotation is discretized (Fenwick et al 2004) . The ratio of the maximum to the average of all non-zero leaf opening times is restricted in the treatment planning process to be less than or equal to a pre-defined modulation factor, which is usually required to be between unity and five. The distance between windings in the helix is controlled by the pitch, which is defined as the fraction of the field width that the couch translates per gantry rotation. The reciprocal of the pitch is the number of gantry rotations over which a point on the gantry rotation axis in the treatment volume resides inside the primary beam (Fenwick et al 2004 , Kissick et al 2005 .
Linac output variations in helical tomotherapy
Throughout the current work it is assumed that the deviation in the HT linac output from the long-term mean at a given gantry angle increment is a random variable, sampled from a Gaussian distribution function. The Gaussian distribution function is characterized by its mean and standard deviation, which are referred to as the random and systematic linac output uncertainties, respectively, and are assumed to be functions of gantry angle. The observed linac output variations are assumed to be samplings of the distributions. For convenience, linac output uncertainties will be referred to as percentages of the long-term linac output average, and uncertainties at a point in the spatial dose distribution will be referred to as percentages of the planned dose at that point.
In a set of HT quality assurance (QA) recommendations developed at the University of Wisconsin (Fenwick et al 2004) and based on the QA recommendations for conventional linear accelerators (Kutcher et al 1994) and serial tomotherapy (Low et al 1998a , 1998b , Woo et al 2003 , it is suggested, as monthly check M2, that the rotational linac output stability be within ±2% of the long-term average. To approximate the effects of the linac output variations on the dose distribution, monthly check M3 (Fenwick et al 2004) may also be performed. Check M3 entails averaging the linac output data over a 30 s time window and ensuring that the resulting smoothed data are within ±2% of the long-term average. The 30 s time window is suggested since it is a representative amount of time that a point in the treatment volume would reside inside the aperture defining the primary radiation beam.
The current paper addresses two issues with checks M2 and M3. First, the maximum and minimum of averaged data are always between or equal to the maximum and minimum of the original data, therefore check M3 is redundant if check M2 already passed, and, conversely, passing check M3 does not imply passage for check M2. Second, the validity of check M3 is based on the assumption that all points in the treatment volume receive equal dose contributions from all beams delivered over a 30 s window. As the intensity profiles of individual fan beams are modulated, and the attenuation and scatter of each fan beam in the patient is dependent on the gantry angle, this is not generally the case.
The effects of random and systematic linac output uncertainties on dose distributions are studied by propagating the linac output uncertainties to the dose distributions for four example HT treatment cases. The sensitivity of the dose uncertainty to the linac output uncertainty is assessed by determining the maximum allowable random and systematic linac output uncertainties that would still result in the passage of a dose uncertainty acceptance criterion, which is based on the criterion for acceptance of check M3, but more comprehensive in that the effects of intensity modulation, beam attenuation and scatter are accounted for. This approach is used for both modeled and measured linac output uncertainties. It is shown that the acceptance threshold for check M2 could likely be increased above ±2%, as cancellation effects between multiple beam directions tend to reduce the magnitude of the systematic dose uncertainty significantly below the maximum and minimum systematic linac output uncertainty.
Materials and methods

Dose expression
The dose, d i , delivered to the voxel indexed by i can be written as a weighted sum over all of the beamlets that contribute to the dose at that voxel:
where m is the intensity at isocentre from the beam delivered over the angular gantry increment indexed by m (m = 1, . . . , M), which is proportional to the linac output over gantry increment m. 
Dose uncertainty
During the treatment planning process, the TomoTherapy TPS calculates the planned dose distribution, d p i , by assuming that the linac output intensities, m , are always equal to the longterm mean intensity, p , and assuming perfect models for the dose calculation and sinogram delivery systems. In actuality, m , D ijm and w jm are all random variables due to uncertainties in linac output, the dose calculation process and the MLC leaf opening times, respectively. In the current study, uncertainties in D ijm and w jm are neglected, as the TomoTherapy TPS dose calculation systems (Lu et al 2005) and sinogram delivery systems (Balog et al 1999a (Balog et al , 1999b have been well-studied elsewhere. The focus is thus restricted to the propagation of the uncertainty in m to the dose distribution.
In the current paper it is assumed that m = p + m , where m is a random variable sampled from a Gaussian distribution with a mean of µ m and a standard deviation of σ m . The dose delivered to voxel i can therefore be expressed as (Bevington 2003) as
and
As d i is a linear combination of the Gaussian-distributed random variables, m , for all m, it follows that d i is also a Gaussian-distributed random variable (Larson and Marx 2001) .
Cases and treatment planning
One idealized case and three clinical cases were considered for study. The idealized case, or ring target case, consisted of a ring-shaped dose prescription in a simulated cylindrical phantom with both radius and height of 10 cm. The prescription region had a height of 5 cm, with an annular transverse cross section of 2 cm inner radius and 5 cm outer radius. The ring target case was chosen to represent a symmetric dose distribution with a central avoidance region. The treatment couch was neglected for the ring target in order to ensure that the fan beam intensity profiles would be nearly constant for all delivery angles. The three clinical cases were a hepatocellular carcinoma (HCC) case, a prostate case and a head and neck (H&N) case. The clinical cases were chosen to represent three delivery situations: an off-centre tumour (HCC), a centralized tumour with adjacent avoidance regions (prostate) and a complex situation with multiple planning target volumes (PTVs) and multiple avoidance regions (H&N). The prescription for the HCC case required that 95% of the PTV receive 60 Gy or higher, and the kidneys, spinal cord, stomach, intestine and liver were all considered avoidance structures. For the prostate case, 95% of the PTV was required to receive 70 Gy or higher, and the rectal wall, bladder and penile bulb were considered avoidance structures. The H&N case had the most complex prescription, with four PTVs, each of which was subscripted with the dose in Gy that was prescribed to 95% of its volume: PTV 70 , PTV 60 , PTV 54 and PTV 50 . PTV 70 was the gross tumour volume (GTV) on the righthand side of the patient and was surrounded by PTV 60 , which contained regional lymph nodes. PTV 54 contained both supraclavicular lymph nodes contralateral to the GTV and subclavicular lymph nodes ipsilateral to the tumour. PTV 50 contained subclavicular nodes contralateral to the tumour. Avoidance structures for the H&N case included the spinal cord, larynx, brainstem, left parotid and oral cavity.
All beamlet (D ijm ) calculations were done on a 2.35 × 2.35 × 3 mm 3 grid of voxels for all cases. Since the commercial TomoTherapy treatment planning system (TPS) does not provide the user with individual beamlets in an easily accessible format, D ijm calculations for each case were done with a non-commissioned, in-house, convolution superposition algorithm. The in-house convolution superposition algorithm calculates dose distributions based on CT scans in a similar manner as the algorithm used by the TomoTherapy TPS (Lu et al 2005) , using polyenergetic energy deposition kernels (Hoban et al 1994) based on monoenergetic kernels (Mackie et al 1988) . Delivery sinograms for each case were obtained by minimizing a quadratic objective function of the same form as that used by the commercial TomoTherapy TPS using 500 iterations of the linear least-squares method (Shepard et al 2000) . Although not suitable for clinical treatment planning, dose distributions calculated from the code were suitable for the current study, as the analysis focused on the relative effects of linac output uncertainty on the dose distributions rather than the accuracy of the dose calculation itself.
A list of the delivery and optimization parameters for each case is shown in table 1. Images of the planned dose distributions and cumulative dose volume histograms (DVHs) for all of the optimized plans are shown in the first and second columns of figure 1, respectively.
Dose uncertainty acceptance criterion
Since the dose variation in voxel i, d i , is assumed to be a Gaussian-distributed random variable with mean µ i and standard deviation σ i , the probability, P, that d i is within some fraction, α, of the planned dose can be calculated as follows: Define η i as the binary dose uncertainty acceptance variable for voxel i:
where P accept is the minimum acceptable probability that the delivered dose is within a ±α fraction of the planned dose. An η i value of zero represents a fail, whereas a value of unity represents a pass. The dose uncertainty acceptance criterion is satisfied if equation (5) is satisfied for all of the voxels in the PTV, for an α value of 2% and a P accept value of 95%. This acceptance criterion is based on the HT QA requirement M3 (Fenwick et al 2004) , but it is more comprehensive in that the dose uncertainties in all voxels in the PTV are considered, and the beamlets (D ijm ) and delivery sinogram (w jm ) are directly used in the uncertainty propagation. Thus the nonuniform fan beam intensity profiles, beam attenuation and scatter in the patient are accounted for.
Since approximately 95% of the area under a Gaussian curve is within two standard deviations from the mean, equation (5) can be simplified for a P accept of 95% to
The effects of random and systematic linac output uncertainties on dose distributions were investigated by determining how great µ m and σ m can become before the dose uncertainty acceptance criterion failed to be satisfied for each case described in section 2.3. The analysis was performed for both modeled and measured versions of µ m and σ m .
Modeled linac output uncertainties
Since the Hi-Art TM linac output as a function of gantry angle is known to be sinusoidal in shape (Fenwick et al 2004) , a cosine function was used to model µ m :
The frequency f, represented the number of oscillations in µ m, mod per gantry rotation, and A was the amplitude of the oscillations expressed as a fraction of the planned output intensity, p . σ m was modeled as
where 0 β. The effects of the modeled linac output uncertainties on each of four cases shown in figure 1 were investigated by finding the maximum acceptable amplitude, i.e., the lowest A (0 A) such that the dose uncertainty acceptance criterion was violated. This test was performed for frequency parameters in equation (7) , and for β values between 0% and 5% in increments of 1%.
Measured linac output uncertainties
Linac output variation measurements were obtained by accessing Hi-Art TM monitor chamber data from a Hi-Art TM machine at the University of Wisconsin, as suggested by Fenwick et al (2004) . A data set was chosen that represented an actual scenario in which the linac output variations were outside of the ±2% tolerance required by check M2. The variations returned to acceptable levels of around ±1% after linac servicing.
The monitor chamber data were acquired while the gantry underwent ten rotations with a period of 20 s. During the measurement process, the number of linac pulses per second (trigger rate) was 300 Hz, the monitor unit (MU) rate was 800 MU min −1 , the pitch was zero and the jaw width was 2.45 cm at isocentre. The monitor chamber was read out at a rate of 
Plots of µ m,est and σ m,est are shown in figure 2(b), which were propagated to the dose distributions for all four cases by assuming that µ m,est and σ m,est exhibited periodicity with a period of 51 with respect to the gantry angle index, m. In order to determine the highest acceptable magnitude for the linac output variation data, µ m,est and σ m,est were scaled for all four cases described in section 2.3 until the dose acceptance criterion failed. The exact value ofψ need not be known for the uncertainty propagation analysis. This is because d Table 2 . Summary of the most sensitive systematic linac output uncertainty frequencies and corresponding amplitudes ( f worst and A worst , respectively), and the least sensitive frequencies and corresponding amplitudes ( f best and A best , respectively). Data for random linac output uncertainties of 0% and 5% of the long-term linac output are listed. 
Results and discussion
Acceptance tolerances for modeled systematic and random uncertainties
Using the terminology in section 2.5, the maximum acceptable A values as a function of f, for β values of 0% and 5%, are shown for all four cases in figure 3. Higher curves represent plans that are less sensitive to random and systematic linac output uncertainties. figure 3 is useful for developing intuition regarding the behaviour of µ d i as a function of the parameters f and A. This is because the radial symmetry of the cylindrical phantom and dose prescription about the isocentre resulted in similar intensity profiles for all beams that affected the PTV, making the analysis straightforward. When f is an even integer, the µ m, mod values for two beams that oppose each other have the same sign and values, and therefore do not cancel each other. When f is an odd integer, the µ m, mod values for opposing beams have opposite signs and values, therefore there is some cancellation between the two beams, resulting in spikes in acceptable A values for odd f, as shown in figure 3 . In addition, cancellation is more likely to occur at points that are affected by a relatively high number of beams, as single or opposing beams do not dominate the µ d i calculation at those points. For the ring target case, the voxels that caused the dose uncertainty acceptance criterion to fail first for all f lay on the PTV side of the interface between the PTV and the OAR. These voxels were affected by a relatively low number of beams due to their close proximity to the OAR, and therefore were more sensitive to increases in A.
Since patients are never radially symmetric, the simple intuitive arguments that hold for the ring target case no longer apply, and µ d i becomes more difficult to interpret. In the plots for the clinical cases in figure 3 the behaviour of the maximum acceptable A is a complicated function of f, and a trend of spikes at the odd values of f is not evident, except for the prostate case, which is due to the central location and approximate cylindrical shape of the prostate. The curves in figure 3 for the HCC and H&N cases were lower than those for the prostate case due to the presence of PTVs that were off-centre. The relatively low number of beams and the lack of symmetry in the beam intensities affecting the voxels near the outer peripheries of the off-centre PTVs made cancellation of systematic dose uncertainties from multiple beam directions less likely in those voxels, making them the first to cause the failure of the dose uncertainty acceptance criterion.
Assuming that the maximum allowable A value for any given case is represented by the worst-case scenario, A worst , the corresponding amplitudes for the ring target, HCC, prostate and H&N cases were 4.3%, 4.7%, 5.5% and 3.5%, respectively, for a β value of 0%, and 2.7%, 2.3%, 2.8% and 1.8%, respectively, for a β value of 5%. For each f, the A worst values corresponding to β values from 1% and 4% decreased linearly between those for β values of 0% and 5%. For all four cases, the A worst values occurred at frequencies of 2.0 rot −1 or below, which are representative of systematic linac output uncertainty frequencies that occur in practice (Fenwick et al 2004) .
Dose acceptance curves for an arbitrary α value (α > 0), α new , in the dose uncertainty acceptance criterion can be obtained by scaling the curves on the left-hand column of figure 3 by α new /2%. This follows from the linearity of the binary voxel-based dose uncertainty acceptance criterion in equation (6).
Uncertainty propagation analysis for measured output variations
In order to quantitatively display the dose uncertainties corresponding to the measured output variations, cumulative uncertainty volume histograms (UVHs) are shown for all four cases in figure 4 . The cumulative UVH is defined as which is similar to the definition of the cumulative DVH (Niemierko and Goitein 1991) ) were between 0 and 0.8% for all four cases, and therefore the dose uncertainty acceptance criterion passed for all cases. The scaling of the measured output uncertainties required such that the dose uncertainties failed to satisfy the dose uncertainty acceptance criterion for the ring target, HCC, prostate and H&N cases were 6.6, 2.9, 8.4 and 3.4, respectively. As the plot of measured linac output variations shown in figure 2(a) contains points that are outside of the acceptance threshold for check M2, this suggests that the tolerance of ±2% is more conservative than necessary in practice.
Relationship between modeled and measured linac output uncertainties
A crude estimate for the scaling factor for the measured uncertainties that will result in the failure of the dose uncertainty acceptance criterion can be calculated using data from the cases of the modeled linac output uncertainties. By taking a conservative approach in which it is assumed that A worst for an arbitrary case is modeled as a function of β using the data from the H&N case, which was the worst-case scenario for the cases of modeled linac output uncertainties examined in the current work, A worst can be expressed as a function of β as
where the A H&N worst β=0%
and A H&N worst β=5% data were taken from table 2. Assume now, referring to figure 2(b), that µ m,est can be approximately represented as a cosine function, shifted by −180
• with an amplitude of 1.5%, and the σ m,est data can be represented by their average overall gantry angles, which is 0.6%. An estimate of the maximum allowable scaling factor for the measured data, a, can be calculated by substituting 1.5a and 0.6a for A worst and β respectively, into equation (11), and solving for a. This process yields an a of 2.0, which is less than the lowest acceptable scaling value for the measured data, which was 2.9 for the HCC case, and therefore a safe estimate.
A simple check for the acceptability of linac output variations
A simple check for assessing the acceptability of a set of linac output variations is to associate the maximum of µ m,est p (m = 1, . . . , 51) with a sinusoidal amplitude, A est . Conservatively assuming that µ m,est has a frequency of f worst (although µ m,est may have sinusoidal components of multiple different frequencies), a worst-case value of β can be derived from equation (11) by letting A worst = A est and then solving for β. The check fails if the average value of σ m,est is greater than β, and linac servicing will be required.
Two examples of simulated linac output variations that are on the borderline of failing the check are shown for three gantry rotations in figure 5. Figure 5 (a) shows output variations that were sampled at each gantry angle increment from a Gaussian function with mean given by equation (7), with f = 2.0 and A = 3.06%, and standard deviation given by equation (8), with β = 1%. Figure 5(b) shows output variations that were sampled in the same way as those in figure 5(a) , except that A = 1.8% and β = 5% The A and β parameters used for figures 5(a) and (b) satisfy equation (11). Both of these linac output variation plots have many points that are above the ±2% tolerance of check M2, but the corresponding dose uncertainties are sufficiently low to satisfy the dose uncertainty acceptance criterion.
Conclusions
Assuming that the long-term mean linac output matches the planned value, sinusoidal systematic linac output uncertainties tend to cancel when propagated to the dose distribution, and random dose uncertainties in voxels in the PTV were reduced relative to random linac output uncertainties by about a factor of 1/ √ N , where N = 51/pitch was the number of HT beams affecting the voxel.
The ±2% linac output variation threshold for passage of check M2 was shown to be overly conservative, as, for all four cases; the dose uncertainty acceptance criterion is satisfied for modeled sinusoidal systematic and random linac output uncertainties of 1.8% and 5%, respectively, which resulted in linac output variations that were well above 5%, as shown in figure 5(b) . This point was demonstrated for measured linac output variations also, as variations that failed to pass check M2 only failed to satisfy the dose uncertainty acceptance criterion for one of the cases after being scaled by a factor of around three.
All four cases were most sensitive to sinusoidal systematic linac output uncertainties with frequencies of 2 rot −1 or less, which are representative of the frequencies that occur in practice. Although the prostate and ring target cases satisfied the dose uncertainty acceptance criterion for sinusoidal systematic linac output uncertainties with amplitudes above 20%, such high amplitudes should never be allowed in practice, as cancellation of the corresponding systematic linac output uncertainty will only occur in fortuitous cases. A new output variation check has therefore been suggested that is based on the worst-case findings of the modeled systematic linac output uncertainty.
